Medicament for treating chicken colibacillosis and preparation method thereof

Abstract

The invention discloses a medicament for treating chicken colibacillosis, which is prepared from the following raw medicines in parts by weight: 30-50 parts of sophora alopecuroides, 30-50 parts of dandelion, 10-25 parts of rhizoma cyperi, 10-25 parts of Chinese pulsatilla and 5-15 parts of plantain herb. The medicament for treating chicken colibacillosis, which is provided by the invention, is a pure traditional Chinese medicine preparation, has the functions of resisting bacteria, diminishing inflammation and relieving diarrhoea, and can be used for treating and preventing chicken colibacillosis. Compared with the condition that drug residues and drug resistance are generated when antibiotics are used for treating chicken colibacillosis, the safety of the medicament is obviously improved, and the effect of the medicament is exact; and the medicament can be popularized and applied to effectively lower the risk of drug residues in poultry and egg products.

Description

technical field [0001] The invention belongs to the technical field of prevention and treatment of chicken colibacillosis, and in particular relates to a medicine for treating chicken colibacillosis and a preparation method thereof. Background technique [0002] Chicken colibacillosis is an infectious disease caused by certain serotypes of certain pathogenic Escherichia coli. Since it was first reported by Lignieres in 1894, the discovery of chicken coli disease spread all over the world very quickly, and chickens of all ages can be sick, mostly with young chickens and middle-aged chickens. The morbidity rate is 11% to 69%, and the fatality rate is 40.2% to 90.3%. It is mixed with other pathogens, and the mortality rate is higher, which often brings huge economic losses to the chicken industry. The clinical manifestations are a variety of symptoms, the more common ones are Escherichia coli sepsis, granuloma, pericarditis, perihepatitis, air sac inflammation, enteritis, omph...

AI Technical Summary

Problems solved by technology

[0003] At present, the prevention and treatment of chicken colibacillosis has the following problems: the one is that there are many pathogenic colibacillary serotypes (there are more than 60 kinds of chicken pathogenic colibacillary serotypes reported now), and the existing vaccines cannot effectively control

Second, due to the extensive use of antibiotics and chemical antibacterial drugs, Escherichia coli has developed extensive drug resistance, resulting in a continuous decline in the therapeutic effect. Clinically, the dose has to be increased and the administration time has been prolonged, which greatly increases the difficulty and cost of treatment; Third, antibiotics and chemical drugs form harmful residues in products such as chicken, offal, and eggs, endangering food safety

However, there are still the following problems: one is that the traditional Chinese medicine for the treatment of colibacillosis is mainly in the form of powder, which cannot be mixed for administration, and it is inconvenient to use in modern intensive farms; the other is that most of them stay at the level of empirical prescriptions, and no standardized clinical trials have been carried out. cannot prove its effectiveness from the perspective of modern epidemiology; the third is that its mechanism of action has not been clarified from the perspective of modern pharmacology

Images